ask="19.68"
ask_size="200"
average_daily_volume="147940"
bid="12.00"
bid_size="100"
book_value="6.55"
change="-0.84"
change_from_200_day_moving_average="1.54"
change_from_50_day_moving_average="0.75"
change_from_52_week_high="-2.08"
change_From_52_week_low="5.35"
change_in_percent="-4.60%"
close="17.42"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.11"
eps_estimate_next_quarter="-0.78"
eps_estimate_next_year="-1.57"
ex_dividend_date="N/A"
float_shares="11609000"
high="18.67"
high_52_weeks="19.50"
last_trade_date="3/2/2017"
last_trade_price="17.42"
last_trade_size="4376"
last_trade_time="4:00pm"
low="17.28"
low_52_weeks="12.07"
market_capitalization="382.93M"
moving_average_200_day="15.88"
moving_average_50_day="16.67"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.25"
open="18.04"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+9.70%"
percent_change_from_50_day_moving_average="+4.49%"
percent_change_from_52_week_high="-10.67%"
percent_change_from_52_week_low="+44.32%"
previous_close="18.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.79"
price_per_sales="379.03"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="210726"
weeks_range_52="12.07 - 19.50"
